Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 90451-90500 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05255471
MITO 35B: Olaparib Beyond Progression Compared to Platinum Chemotherapy After Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer Patients.
PHASE3Recruiting
200 participants
Started: Jan 21, 2022 · Completed: Jan 21, 2028
1 condition1 sponsor1 location
NCT06162325
Venetoclax in Combination With Standard Induction and Consolidation Chemotherapy in Newly Diagnosed Young AML Patients
N/AEnrolling by invitation
45 participants
Started: Jan 21, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04900506
Surgical Approach in Hemiarthroplasty. A Randomized Clinical Trial Comparing Posterior and Anterior Approach
NAActive, not recruiting
210 participants
Started: Jan 21, 2022 · Completed: Oct 1, 2025
4 conditions2 sponsors2 locations
NCT05234658
Study of an Artificial Human Skin Medicine for Patients With Basal Cell Carcinoma Undergoing Reconstructive Surgery
PHASE2Recruiting
21 participants
Started: Jan 21, 2022 · Completed: Dec 1, 2024
1 condition1 sponsor4 locations
NCT05143970
A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors
PHASE1Recruiting
27 participants
Started: Jan 21, 2022 · Completed: Feb 28, 2026
9 conditions2 sponsors1 location
NCT05245058
SPH5030 Tablets in Subjects With Advanced Her2-positive Solid Tumors
EARLY_PHASE1Recruiting
150 participants
Started: Jan 21, 2022 · Completed: Dec 21, 2025
1 condition1 sponsor17 locations
NCT05300308
Lymphoedema and Nocturia/Nocturnal Polyuria After Pelvic LND for Urogenital Cancer
N/ARecruiting
150 participants
Started: Jan 21, 2022 · Completed: Nov 30, 2026
4 conditions1 sponsor1 location
NCT06781840
Promoting Health Through Play Program: Improving Parent and Child Outcomes
NARecruiting
10 participants
Started: Jan 21, 2022 · Completed: Dec 30, 2025
2 conditions2 sponsors1 location
NCT05699629
Prospective Coronary Heart Disease Cohort
N/ARecruiting
50,000 participants
Started: Jan 21, 2022 · Completed: Jan 21, 2027
2 conditions5 sponsors1 location
NCT05886660
Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance
PHASE2Recruiting
30 participants
Started: Jan 21, 2022 · Completed: Sep 30, 2024
3 conditions2 sponsors1 location
NCT04899687
Study of Dextromethorphan in OCD and Related Disorders
PHASE2Recruiting
60 participants
Started: Jan 20, 2022 · Completed: Dec 1, 2026
4 conditions2 sponsors1 location
NCT03977779
Evaluation of the Use of a Biodegradable Endoprothesis in the Prevention of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis
NARecruiting
46 participants
Started: Jan 20, 2022 · Completed: Dec 15, 2024
3 conditions1 sponsor1 location
NCT05840809
Pharmacokinetics of Drugs Used to Treat Drug Sensitive Tuberculosis in Breastfeeding Mother-infant Pairs
N/AActive, not recruiting
20 participants
Started: Jan 20, 2022 · Completed: Jan 29, 2026
3 conditions2 sponsors1 location
NCT05113004
New Clinical End-points in Patients With Primary Sjögren's Syndrome
PHASE2Recruiting
300 participants
Started: Jan 20, 2022 · Completed: Oct 1, 2025
1 condition1 sponsor7 locations
NCT05717738
Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma
N/ARecruiting
300 participants
Started: Jan 20, 2022 · Completed: Dec 31, 2024
1 condition6 sponsors4 locations
NCT05010473
Cortical Contributions to Frequency Following Responses and Modulation
NAEnrolling by invitation
70 participants
Started: Jan 20, 2022 · Completed: Jan 20, 2026
1 condition2 sponsors1 location
NCT05809167
Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Lymphoblastic Leukemia Undergoing Allo-HSCT
PHASE2Recruiting
55 participants
Started: Jan 20, 2022 · Completed: Jan 20, 2026
2 conditions1 sponsor1 location
NCT05383183
Efficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's Disease
PHASE4Recruiting
630 participants
Started: Jan 20, 2022 · Completed: Dec 9, 2025
1 condition1 sponsor4 locations
NCT05149326
KN046 in Subjects With Advanced Pancreatic Ductal Adenocarcinoma.
PHASE3Active, not recruiting
408 participants
Started: Jan 20, 2022 · Completed: Aug 30, 2024
1 condition1 sponsor65 locations
NCT05292846
Uninterrupted Direct-acting Oral Anticoagulation in Patients Undergoing Transradial Percutaneous Coronary Procedures
PHASE4Recruiting
200 participants
Started: Jan 20, 2022 · Completed: Apr 20, 2024
3 conditions1 sponsor4 locations
NCT05127005
Efficacy of Trapeziectomy Versus Sham Surgery in the Treatment of Osteoarthritis at the Base of the Thumb
NARecruiting
132 participants
Started: Jan 20, 2022 · Completed: Dec 31, 2029
1 condition4 sponsors4 locations
NCT04594980
Minimally Invasive Decompression and Fusion Versus Open for Degenerative Lumbar Stenosis
NAActive, not recruiting
96 participants
Started: Jan 20, 2022 · Completed: Feb 28, 2026
2 conditions1 sponsor1 location
NCT05218356
Phase IIa Randomized Placebo Controlled Clinical Study of Codivir in Hospitalized Patients with Moderate COVID-19
PHASE2Recruiting
130 participants
Started: Jan 20, 2022 · Completed: Jul 20, 2025
1 condition1 sponsor5 locations
NCT05193617
Penpulimab Combined With GP ± Anlotinib as Neoadjuvant Therapy in Locoregionally Advanced Nasopharyngeal Carcinoma
PHASE2Active, not recruiting
104 participants
Started: Jan 20, 2022 · Completed: Jan 1, 2027
1 condition1 sponsor1 location
NCT05199662
Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion With TNK (RESILIENT
PHASE3Recruiting
466 participants
Started: Jan 20, 2022 · Completed: Jul 31, 2027
1 condition5 sponsors15 locations
NCT05227287
ADH1 and ADH2 Disease Monitoring Study (DMS)
N/AActive, not recruiting
95 participants
Started: Jan 20, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor27 locations
NCT06059612
Treatment of Upper Cluneal Nerve Entrapment Syndrome for Reduction of Low Back Pain
NARecruiting
78 participants
Started: Jan 20, 2022 · Completed: Oct 1, 2025
1 condition1 sponsor1 location
NCT04688398
Study of the Impact of Fatty Acids From Seal Oil on the Relief of Symptoms Associated With Rheumatoid Arthritis
NARecruiting
130 participants
Started: Jan 20, 2022 · Completed: Mar 31, 2025
1 condition3 sponsors1 location
NCT04895488
Cognitive Effects of Adjuvant Vortioxetine in Early Schizophrenia
PHASE2/PHASE3Recruiting
37 participants
Started: Jan 20, 2022 · Completed: Dec 20, 2025
2 conditions1 sponsor1 location
NCT05219903
National, Multicenter, Retrospective, Prospective Study to Evaluate Pediatric Gastrointestinal Eosinophilic Disorders
N/ARecruiting
300 participants
Started: Jan 20, 2022 · Completed: Jan 31, 2027
4 conditions2 sponsors1 location
NCT04626050
General Psychological Distress, PTSD, and Co-Morbidities in Healthcare Workers Consequent to COVID-19
NARecruiting
120 participants
Started: Jan 20, 2022 · Completed: Apr 30, 2028
2 conditions1 sponsor1 location
NCT05058846
Pilot Study of Pancreatic Cancer Screening
N/ARecruiting
250 participants
Started: Jan 20, 2022 · Completed: Jan 31, 2032
1 condition1 sponsor1 location
NCT04987112
Intratumoral CAN1012(Selective TLR7 Agonist) in Subjects With Solid Tumors
PHASE1Recruiting
36 participants
Started: Jan 20, 2022 · Completed: Dec 30, 2024
2 conditions1 sponsor2 locations
NCT04975737
Study of the Safety and Efficacy of the Subunit Recombinant Tuberculosis Vaccine GamTBvac
PHASE3Recruiting
7,180 participants
Started: Jan 20, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT05823714
Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Myeloid Leukemia and Myelodysplastic Syndromes Undergoing Allo-HSCT
PHASE2Recruiting
70 participants
Started: Jan 20, 2022 · Completed: Jan 20, 2026
3 conditions1 sponsor1 location
NCT05525650
Comparative Evaluation of Safety and Immune Activity of New Immunotherapeutic Agents for HDM Allergic Rhinitis Patients
PHASE1Enrolling by invitation
54 participants
Started: Jan 20, 2022 · Completed: Jun 15, 2025
3 conditions1 sponsor1 location
NCT05159440
First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer
PHASE1Active, not recruiting
70 participants
Started: Jan 20, 2022 · Completed: Dec 15, 2025
4 conditions2 sponsors8 locations
NCT05033288
Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone
N/ARecruiting
72 participants
Started: Jan 20, 2022 · Completed: Aug 30, 2028
5 conditions1 sponsor3 locations
NCT05170919
Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients with Advanced Stage Cancer
PHASE2Enrolling by invitation
170 participants
Started: Jan 20, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05627453
Arm-in-Arm Gait Training Trial
NARecruiting
132 participants
Started: Jan 20, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06557707
Cardiovascular Health & Early Stress
N/ARecruiting
120 participants
Started: Jan 20, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT06103331
Fungal Surveillance in Bangladesh
N/ARecruiting
800 participants
Started: Jan 20, 2022 · Completed: Sep 30, 2026
1 condition3 sponsors1 location
NCT05089916
Radiation During Osimertinib Treatment: a Safety and Efficacy Cohort Study
PHASE2Active, not recruiting
40 participants
Started: Jan 20, 2022 · Completed: Dec 31, 2026
3 conditions2 sponsors1 location
NCT06012227
Assessment Metabolic Flexibility in Middle-aged Individuals: The Nutritional Impact of Cheese Consumption
NARecruiting
105 participants
Started: Jan 20, 2022 · Completed: Dec 20, 2026
2 conditions1 sponsor1 location
NCT04878627
Role of CBD in Regulating Meal Time Anxiety in Anorexia Nervosa
EARLY_PHASE1Active, not recruiting
40 participants
Started: Jan 20, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05767060
BAT7104 Injection in Patients with Advanced Malignant Tumors.
PHASE1Recruiting
42 participants
Started: Jan 20, 2022 · Completed: Dec 20, 2024
1 condition2 sponsors1 location
NCT05134454
Atrial Fibrillation Screening Post Ischemic Cerebrovascular Events
NARecruiting
3,300 participants
Started: Jan 20, 2022 · Completed: Dec 31, 2027
2 conditions7 sponsors1 location
NCT04893577
EDTA Eye Drops Compared to Abreva for Herpes Simplex Virus Eruptions
PHASE2Enrolling by invitation
20 participants
Started: Jan 20, 2022 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT05013996
Impact of a Structured Clinical Assessment MIDSA, Its Feedback and Support for Change on Commitment to Care of Perpetrators of Sexual Offenses
NARecruiting
200 participants
Started: Jan 20, 2022 · Completed: Jan 20, 2026
1 condition1 sponsor5 locations
NCT05064280
Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
PHASE2Recruiting
104 participants
Started: Jan 20, 2022 · Completed: Feb 28, 2028
2 conditions2 sponsors1 location